Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.62% is 23% below its 5-year average of 17.70%, near the low end of its 5-year range (13.62%–23.54%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.06% below its 12-month average of 14.65%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
13.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
14.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
16.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
17.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
14.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
12.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
11.04%
CURRENT VS TTM AVG
-7.06%
CURRENT VS 3Y AVG
-19.42%
CURRENT VS 5Y AVG
-23.04%
CURRENT VS 10Y AVG
-4.81%
CURRENT VS 15Y AVG
+10.61%
CURRENT VS 20Y AVG
+23.42%
SECTOR MEDIAN · HEALTHCARE
8.78%
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
+55.13%
vs the sector median at left
West Pharmaceutical Services, Inc.
Market Cap
$24.73B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
14.65%
3Y Avg
16.90%
5Y Avg
17.70%
Market Cap
$24.54B
Return on Invested Capital (ROIC)
20.58%
TTM Avg
10.42%
3Y Avg
9.36%
5Y Avg
7.13%
Market Cap
$24.03B
Return on Invested Capital (ROIC)
-29.70%
TTM Avg
-31.12%
3Y Avg
-12.69%
5Y Avg
0.19%
Market Cap
$23.31B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
Market Cap
$26.21B
Return on Invested Capital (ROIC)
8.43%
TTM Avg
7.70%
3Y Avg
8.24%
5Y Avg
10.04%
Market Cap
$23.22B
Return on Invested Capital (ROIC)
8.47%
TTM Avg
7.82%
3Y Avg
7.13%
5Y Avg
6.49%
Market Cap
$26.44B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$21.88B
Return on Invested Capital (ROIC)
16.13%
TTM Avg
15.79%
3Y Avg
14.56%
5Y Avg
13.09%
Market Cap
$29.04B
Return on Invested Capital (ROIC)
35.46%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.73B | 13.62% | 14.65% | 16.90% | 17.70% |
| Incyte Corporation (INCY)vs › | $24.54B | 20.58% | 10.42% | 9.36% | 7.13% |
| Moderna, Inc. (MRNA)vs › | $24.03B | -29.70% | -31.12% | -12.69% | 0.19% |
| BioNTech SE (BNTX)vs › | $23.31B | -3.14% | -4.79% | 9.55% | 20.42% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.21B | 8.43% | 7.70% | 8.24% | 10.04% |
| STERIS plc (STE)vs › | $23.22B | 8.47% | 7.82% | 7.13% | 6.49% |
| Labcorp Holdings Inc. (LH)vs › | $26.44B | 7.39% | 6.30% | 5.64% | 7.56% |
| United Therapeutics Corporation (UTHR)vs › | $21.88B | 16.13% | 15.79% | 14.56% | 13.09% |
| Mettler-Toledo International Inc. (MTD)vs › | $29.04B | 35.46% | 38.26% | 37.51% | 36.01% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.60B | 13.74% | 4.77% | -7.01% | -13.46% |
ROIC
13.6%
ROE
18.9%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 13.62% |
| 2024-12-31 | 15.69% |
| 2023-12-31 | 17.81% |
| 2022-12-31 | 20.49% |
| 2021-12-31 | 23.54% |
| 2020-12-31 | 15.04% |
| 2019-12-31 | 11.87% |
| 2018-12-31 | 12.52% |
| 2017-12-31 | 9.44% |
| 2016-12-31 | 10.57% |
| 2015-12-31 | 6.80% |
| 2014-12-31 | 9.18% |
| 2013-12-31 | 8.03% |
| 2012-12-31 | 7.28% |
| 2011-12-31 | 7.33% |
| 2010-12-31 | 7.80% |
| 2009-12-31 | 8.12% |
| 2008-12-31 | 9.65% |
| 2007-12-31 | 9.08% |
| 2006-12-31 | 9.92% |
| 2005-12-31 | 10.47% |
| 2004-12-31 | 8.45% |
| 2003-12-31 | 6.85% |
| 2002-12-31 | 4.37% |
| 2001-12-31 | 6.41% |
| 2000-12-31 | 3.83% |
| 1999-12-31 | 9.43% |
| 1998-12-31 | 3.55% |
| 1997-12-31 | 11.30% |
| 1996-12-31 | 7.75% |
